MRI and cognitive patterns in relapsing-remitting multiple sclerosis

L Pugnetti1, L Mendozzi, A Motta

  • 1IRCCS S. Maria Nascente, Multiple Sclerosis University Center, Milan, Italy.

Insights

Magnetic resonance imaging (MRI) patterns correlate with cognitive function in multiple sclerosis (MS) patients. Specific MRI lesion types and atrophy predict neuropsychological deficits, suggesting distinct disease progression pathways.

Area of Science:

  • Neuroscience
  • Radiology
  • Clinical Neurology

Background:

  • Relapsing-remitting multiple sclerosis (MS) presents with diverse neurological and cognitive impairments.
  • Understanding the relationship between brain imaging findings and neuropsychological outcomes is crucial for predicting MS progression.

Purpose of the Study:

  • To investigate the correlation between magnetic resonance imaging (MRI) findings and performance on the Luria-Nebraska Neuropsychological Battery (LNNB) in patients with relapsing-remitting MS.
  • To identify specific MRI patterns associated with distinct cognitive profiles and potential disease trajectories.

Main Methods:

  • Sixty-four patients with relapsing-remitting MS underwent MRI and LNNB assessments.
  • MRI scans were evaluated for lesion type (discrete, confluent, large), size, and presence of parenchymal atrophy.
  • Patients were categorized into five groups based on MRI characteristics.

Main Results:

  • Patients with confluent lesions and parenchymal atrophy (Groups 2 and 3) exhibited the most significant LNNB impairments, though not dementia.
  • Patients with discrete white matter lesions (Group 1) and few small lesions (Group 5) were cognitively intact, despite differing ages and MRI patterns.
  • A distinct group (Group 4) with large discrete lesions showed mild deficits in attention and abstract thinking, potentially indicating localized biological activity.

Conclusions:

  • MRI patterns, including lesion type and atrophy, are associated with specific cognitive deficits in MS.
  • The findings suggest that certain MRI findings may predict distinct clinical outcomes, ranging from cognitive stability to progressive brain tissue loss.
  • Further research into the dynamic nature of MS lesions and their impact on cognitive function is warranted.